4//SEC Filing
Tsuchimoto Kim R 4
Accession 0001437749-24-000480
CIK 0001645469other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:34 PM ET
Size
14.9 KB
Accession
0001437749-24-000480
Insider Transaction Report
Form 4
Tsuchimoto Kim R
Director
Transactions
- Exercise/Conversion
Common Stock
2023-12-31+9,957→ 47,943 total - Tax Payment
Common Stock
2023-12-31$0.34/sh−4,073$1,386→ 43,870 total - Exercise/Conversion
Common Stock
2024-01-01+1,231→ 45,101 total - Tax Payment
Common Stock
2024-01-01$0.34/sh−505$172→ 44,596 total - Exercise/Conversion
Restricted Stock Units
2024-01-01−1,231→ 94,325 total→ Common Stock (1,231 underlying) - Exercise/Conversion
Restricted Stock Units
2023-12-31−9,957→ 95,556 total→ Common Stock (9,957 underlying)
Footnotes (6)
- [F1]Represents shares acquired on vesting and settlement of restricted stock units.
- [F2]Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
- [F3]On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- [F4]On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- [F5]On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- [F6]On January 31, 2020 the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
Related Parties
1- filerCIK 0001333516
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 7:34 PM ET
- Size
- 14.9 KB